Beta Technology Ltd Company Profile

16:57 EST 12th December 2018 | BioPortfolio

Beta Technology Ltd is a private company established in 1984, by Dr Bob Keown OBE.

Originally a lecturer in Metallurgy at Sheffield University, Bob set up his own consultancy company in 1984 and later went on to set up an employment agency hiring out scientists to industry such as British Steel (Corus), the National Physical Laboratory (NPL) and the Central Science Laboratory (CSL).

Since then the company has grown in size and taken on more public sector contracts from organisations such as the DTI, DEFRA (formally known as MAFF), Yorkshire Forward, European Commission (EC), Advantage West Midlands and One NorthEast.

Today Beta's main objective is to encourage small and large companies throughout the UK to be more technically proactive.

Beta does this by providing assistance to companies wanting to apply for European research and development funding and by providing innovation services to companies to help them develop, promote and acquire new technologies.

Beta is the designated UK National Contact Point (NCP) for a number of areas of FP6 including SMEs, Life Sciences and Research and Innovation. Additionally, Beta is the Innovation Relay Centre (IRC) for the Yorkshire and Humber region and is a partner in 5 FP6 projects.

Beta's head office is located in Doncaster, South Yorkshire and we have a subsidiary office in Middlesbrough on Teesside. The Company currently employs 28 full time staff and 40 consultants and researchers.


Barclay CourtDoncaster Carr
South Yorkshire
United Kingdom


Phone: 44 (0) 1302 322633
Fax: 44 (0) 1302 388800

News Articles [418 Associated News Articles listed on BioPortfolio]

BioCure Technology Inc. Provides Update on Pre-Clinical Trial of Interferon-beta 1b.

BioCure Technology Inc. (CSE:CURE, OTCQB;BICTF) ("BioCure" or the "Company") is pleased to announce that its wholly owned subsidiary BiocurePharm Corporation ("BP Korea"), has implemented the preclini...

Researchers Use CRISPR Technology to Treat Beta Thalassemia Patients

The first human trial in the U.S. using CRISPR gene-editing technology will soon be launched by Vertex Pharmaceuticals and CRISPR Therapeutics. The developers will conduct the trial to evaluate CTX001...

Human medicines European public assessment report (EPAR): Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron), dinutuximab beta, Revision: 4, Authorised

Advice about beta-blockers

4 June 2018: Helen Williams, spokesperson on cardiovascular medicine at the Royal Pharmaceutical Society, spoke to the Daily Mail about beta-blockers. “Beta-blockers can cause a general slowing d...

Transgenic Mice Expressing CNO-sensitive Gq- or Gs-coupled Designer Receptors Selectively in Pancreatic Beta Cells

Impaired functioning of pancreatic beta cells is a key hallmark of type 2 diabetes. Beta cell function is modulated by the actions of different classes of heterotrimeric G proteins. The functional con...

Avivagen (VIV) - Antibiotic-free alternative for animal feed

Edison Investment Research - Pharmaceutical & healthcare - Avivagen: Avivagen is advancing feed additives based on its OxC-beta (fully oxidized beta-carotene) technology, which improves immune functio...

Beta-Blocker Use in First Trimester Seems Safe

Use of beta-blockers in early pregnancy is not associated with significantly increased risk for congenital malformations, according to a study in the Annals of...

RadianceTx raises initial funding for glaucoma therapy

The company will use the investment to fund development of its Beta Ophthalmic System for delivery of beta irradiation therapy to enhance glaucoma surgery outcomes. This new beta The post RadianceTx ...

PubMed Articles [1071 Associated PubMed Articles listed on BioPortfolio]

TGF-beta/TGF-beta RII/CLC-3 axis promotes cognitive disorders in diabetes.

Transforming growth factor beta (TGF-beta) and Chloride channel-3 (CLC-3) are critical for inflammatory response, cellular proliferation and apoptosis in hippocampus neurons. However, the relationship...

Ophthalmic Technology Assessment: The Use of Beta-Blockers for the Treatment of Periocular Hemangiomas in Infants.

To review the published literature assessing the efficacy of beta-blockers for the treatment of periocular hemangioma in infants.

Production of liquefied fuel from depolymerization of kraft lignin over a novel modified nickel/H-beta catalyst.

In this study, a novel modified nickel/H-beta (Ni/DeAl-beta) catalyst, which has active acidic sites and hydrogen binding sites, was prepared and used to produce liquefied fuel from lignin. The bifunc...

Beta-cypermethrin exposure affects female reproduction by enhancing oxidative stress in mice uterine tissue.

This study aimed to investigate the toxicity mechanism of beta-cypermethrin (beta-CYP) on fertility in female mice. Eighty female mice were randomly assigned to four groups of 20 mice each: one contro...

Demonstration of Single-Barium-Ion Sensitivity for Neutrinoless Double-Beta Decay Using Single-Molecule Fluorescence Imaging.

A new method to tag the barium daughter in the double-beta decay of ^{136}Xe is reported. Using the technique of single molecule fluorescent imaging (SMFI), individual barium dication (Ba^{++}) resolu...

Clinical Trials [2669 Associated Clinical Trials listed on BioPortfolio]

Investigating the Effects of Beta-Hydroxy-Beta-Methylbutyrate on Glucose Handling in Older and Younger Men.

We intend to examine the effect of a commercially available nutritional supplement, Beta-hydroxy-beta-methylbutyrate(HMB) on whole-body responses to a sugar load.

Thalassemia Treatment Based on the Stem Cell Technology

In order to study the transplantation effect of hematopoetic stem cells from beta-thalassemia induced pluripotent stem cells. We applied clinical grade source of autologous hematopoietic s...

Interaction Study SLV337/Simvastatin

To investigate the effect of multiple doses of SLV337 on the pharmacokinetics of simvastatin and simvastatin acid when co-administered in healthy male subjects

Phase I BP Interferon (IFN) Beta-004

Phase I study aiming at: - establishing the pharmacokinetic profile of interferon beta-1a after i.v. administration of the formulation BioPartners IFN beta-1a without albumin (HSA...

Is IFN-Beta Treatment in MS Useful After a Washout Period in Patients With Neutralizing Antibodies to Interferon Beta

This study is to find out if Interferon-beta (IFN-beta) can recover its effectiveness after a washout period in patients with Multiple Sclerosis who have previously developed neutralizing ...

Companies [530 Associated Companies listed on BioPortfolio]

Beta Technology Ltd

Beta Technology Ltd is a private company established in 1984, by Dr Bob Keown OBE. Originally a lecturer in Metallurgy at Sheffield University, Bob set up his own consultancy company in 1984 and later...

Beta Amyloid Org

Beta keeps up details of Alzheimer Research Labs, Alzheimer Research conferences around the world. Amyloid peptides being one of the major culprit of the Alzheimer Disease so our goal is t...

BETA Healthcare Group

BETA Healthcare Group provides healthcare professional liability coverage to more than 150 hospitals and healthcare facilities in California. As the leading choice of liability in...


Beta-Cell is engaged in the development and commercialisation of innovative cell and drug therapies for the treatment of diabetes. The primary therapeutic focus of the company is on beta-cells, the hi...


Elan Corporation, plc is a neuroscience-based biotechnology company that is focused on discovering, developing, manufacturing and marketing advanced therapies in neurology, autoimmune diseases, and se...

More Information about "Beta Technology Ltd" on BioPortfolio

We have published hundreds of Beta Technology Ltd news stories on BioPortfolio along with dozens of Beta Technology Ltd Clinical Trials and PubMed Articles about Beta Technology Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Beta Technology Ltd Companies in our database. You can also find out about relevant Beta Technology Ltd Drugs and Medications on this site too.

Quick Search


Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Corporate Database Quicklinks

Searches Linking to this Company Record